CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 44,025 shares (to pay taxes)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.11 ($21,100)
- 4 Open-market sale Director sold 3,571,428 shares at $1.59 ($5,678,571)
- 4 Open-market sale Director sold 3,571,428 shares at $1.59 ($5,678,571)
- 4 Open-market buy Gen Counsel & Corporate Sec bought 20,000 shares at $1.54 ($30,800)
- 4 Open-market buy CHIEF ACCOUNTING OFFICER bought 20,000 shares at $1.42 ($28,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO gave up 41,687 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 58,054 shares (to pay taxes)
Page 2 of 8 · 142 filings